XML 25 R14.htm IDEA: XBRL DOCUMENT v3.20.2
Note 7 - Financial Instruments
9 Months Ended
Sep. 30, 2020
Notes to Financial Statements  
Financial Instruments Disclosure [Text Block]
7.
FINANCIAL INSTRUMENTS
 
Investments—Trading
 
Investments-trading consisted of the following.
 
INVESTMENTS - TRADING
(Dollars in Thousands)
 
   
September 30, 2020
   
December 31, 2019
 
U.S. government agency MBS and CMOs
  $
172,865
    $
196,146
 
U.S. government agency debt securities
   
4,791
     
14,680
 
RMBS
   
15
     
15
 
U.S. Treasury securities
   
9,917
     
11,105
 
ABS
   
1
     
100
 
SBA loans
   
10,104
     
27,634
 
Corporate bonds and redeemable preferred stock
   
28,375
     
38,503
 
Foreign government bonds
   
681
     
844
 
Municipal bonds
   
3,271
     
13,737
 
Certificates of deposit
   
812
     
841
 
Derivatives
   
6,172
     
3,686
 
Equity securities
   
267
     
561
 
Investments-trading
  $
237,271
    $
307,852
 
 

 
Trading Securities Sold,
Not
Yet Purchased
 
Trading securities sold,
not
yet purchased consisted of the following.
 
TRADING SECURITIES SOLD,
NOT
YET PURCHASED
(Dollars in Thousands)
 
   
September 30, 2020
   
December 31, 2019
 
U.S. government agency debt securities   $
4
    $
-
 
U.S. Treasury securities
   
13,172
     
16,827
 
Corporate bonds and redeemable preferred stock
   
33,941
     
58,083
 
Municipal bonds
   
20
     
20
 
Derivatives
   
5,227
     
3,017
 
Equity securities    
2,255
     
-
 
Trading securities sold, not yet purchased
  $
54,619
    $
77,947
 
 
The Company manages its exposure to changes in interest rates for the interest rate sensitive securities it holds by entering into offsetting short positions for similar fixed rate securities. See note
5
for realized and unrealized gains recognized on investments-trading.
 
Other Investments, at fair value
 
Other investments, at fair value consisted of the following.
 
OTHER INVESTMENTS, AT FAIR VALUE
(Dollars in Thousands)
 
   
September 30, 2020
 
   
Amortized
   
Carrying
   
Unrealized
 
   
Cost
   
Value
   
Gain / (Loss)
 
Equity securities
  $
16,097
    $
17,051
    $
954
 
Subordinated Notes    
900
     
900
     
-
 
RTLs    
2,243
     
2,266
     
23
 
U.S. Insurance JV
   
1,224
     
1,391
     
167
 
SPAC Fund
   
646
     
745
     
99
 
Residential loans
   
121
     
99
     
(22
)
Other investments, at fair value
  $
21,231
    $
22,452
    $
1,221
 
 
  
   
December 31, 2019
 
   
Amortized
   
Carrying
   
Unrealized
 
   
Cost
   
Value
   
Gain / (Loss)
 
Equity securities
  $
8,598
    $
9,352
    $
754
 
CLOs
   
2,894
     
2,522
     
(372
)
U.S. Insurance JV
   
2,048
     
2,223
     
175
 
SPAC Fund
   
646
     
668
     
22
 
Residential loans
   
129
     
99
     
(30
)
Other investments, at fair value
  $
14,315
    $
14,864
    $
549